Cargando…
Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis)
PURPOSE: Asthma is a common comorbidity in patients with bronchiectasis and has been shown to increase the risk of bronchiectasis exacerbations. This paper explores the impact of comorbid asthma on patients receiving intravenous antibiotic treatment for bronchiectasis exacerbations. METHODS: This wa...
Autores principales: | Hill, Andrew R., Bedi, Pallavi, Cartlidge, Manjit K., Turnbull, Kim, Donaldson, Samantha, Clarke, Andrea, Crowe, Jane, Campbell, Kadiga, Franguylan, Ruzanna, Rossi, Adriano G., Hill, Adam T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968257/ https://www.ncbi.nlm.nih.gov/pubmed/36746812 http://dx.doi.org/10.1007/s00408-023-00601-1 |
Ejemplares similares
-
Dysregulation of prostaglandins, leukotrienes and lipoxin A(4) in bronchiectasis
por: Bedi, Pallavi, et al.
Publicado: (2022) -
‘It’s not one size fits all’: a qualitative study of patients’ and healthcare professionals’ views of self-management for bronchiectasis
por: Kelly, Carol Ann, et al.
Publicado: (2021) -
Feasibility of home initiation of an airway clearance device (SIMEOX) by telecare in people with non-cystic fibrosis bronchiectasis: a pilot study
por: Hamidfar, Rebecca, et al.
Publicado: (2023) -
Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
por: Rømer, Valdemar, et al.
Publicado: (2023) -
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
por: Serisier, David J, et al.
Publicado: (2013)